在药物组合发现中,用于生物医学假设生成的多代理大型语言模型
Qidi Xu1, Claudio Soto2, Mohammad Shahnawaz2
1McWilliams School of Biomedical Informatics, UTHealth Houston, Houston, TX 77030, US.
iScience
|December 9, 2025
概括
本研究介绍了Coated-LLM,这是一种用于在数据稀缺的情况下生成阿尔茨海默病治疗假设的AI框架. 涂层LLM成功预测了有效的药物组合,在体外验证.
科学领域:
- 人工智能的人工智能
- 生物医学研究生物医学研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型语言模型 (LLM) 在科学推理方面表现有前途,但在数据稀缺的领域,它在假设生成方面扎.
- 预测阿尔茨海默氏症 (AD) 等复杂疾病的组合疗法是具有挑战性的,因为数据有限.
研究的目的:
- 引入Coated-LLM,这是一个AI框架,用于预测数据稀缺领域的有效组合疗法,使用AD作为案例研究.
- 利用人工智能驱动的科学合作来克服传统数据驱动预测方法的局限性.
主要方法:
- 覆盖型LLM利用专门的LLM代理人 (研究人员,审稿人,主持人) 进行系统的假设生成和评估.
- 使用上下文学习技术来增强AI的推理能力.
- 该框架使用阿尔茨海默病数据进行了测试,将其性能与传统基于知识的方法进行了比较.
主要成果:
- 涂层LLM在预测阿尔茨海默病治疗疗效方面比传统方法 (0.52) 准确度更高 (0.74).
- 外部验证进一步证实了框架的预测能力,准确度为0.82.2.
- 由Coated-LLM确定的一种新型药物组合在实验中得到验证,可在体外显著降低粉样蛋白聚合.
结论:
- 涂层LLM展示了一个可扩展的方法,用于生物医学研究的假设生成,增强人类的科学推理.
- 人工智能框架显示出加速发现阿尔茨海默氏症等复杂疾病的新疗法战略的巨大潜力.
- 这项工作突出了AI在解决科学发现中的数据稀缺挑战方面的能力.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
223
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
223
Pharmacokinetic Models: Overview
1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K


